40 min listen
Variation in Endpoints for FDA Approved Migraine Therapies
Variation in Endpoints for FDA Approved Migraine Therapies
ratings:
Length:
11 minutes
Released:
Sep 7, 2023
Format:
Podcast episode
Description
Dr. Jessica Ailani talks with Dr. Aaron Kesselheim and Leigh Sharpless about the endpoints used in trials supporting the US FDA approval of medications treating migraine. Read the related article in Neurology. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
Released:
Sep 7, 2023
Format:
Podcast episode
Titles in the series (100)
October 23 2007 Issue: Patterns of Guillain-Barre syndrome in children: Results from a Mexican population by Neurology® Podcast